Medicare Enrolled
Dr. Boris Bagdasarian, D.O.
Hematology & Oncology · Glendale, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bagdasarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bagdasarian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bagdasarian
Dr. Boris Bagdasarian is a hematology & oncology specialist in Glendale, CA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Bagdasarian performed 101,936 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bagdasarian received a total of $35,527 from 102 pharmaceutical and/or device companies across 1530 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bagdasarian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 8% volume in CA
$35,527 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗101,936
Medicare services
Top 8% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
33,265 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
8,557 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 8,257 | $43 | $165 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
7,360 | $0 | $0 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
5,403 | $33 | $126 |
| Denosumab injection (Prolia/Xgeva) | 3,891 | $19 | $71 |
| Paclitaxel chemotherapy injection | 3,763 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,076 | $104 | $421 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,026 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,718 | $8 | $25 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,956 | $99 | $367 |
| Injection, atropine sulfate, 0.01 mg | 1,788 | $0 | $0 |
| Iron infusion (Monoferric) | 1,600 | $16 | $62 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,463 | $8 | $18 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,334 | $1 | $3 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
1,201 | $26 | $101 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,148 | $12 | $48 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
1,090 | $4 | $17 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,001 | $35 | $133 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
991 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 925 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $75 | $297 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
741 | $119 | $467 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
720 | $18 | $71 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
690 | $10 | $33 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
653 | $56 | $227 |
| Bevacizumab biosimilar injection, 10 mg An injection of bevacizumab-awwb, a biosimilar medication, administered in a 10 mg dose. |
570 | $21 | $85 |
| Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 400 | $42 | $159 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
387 | $25 | $98 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
360 | $59 | $228 |
| Injection, irinotecan, 20 mg | 299 | $1 | $5 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
295 | $2 | $7 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
255 | $29 | $117 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
216 | $143 | $572 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
209 | $29 | $115 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
198 | $49 | $203 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
197 | $11 | $44 |
| New patient office visit, complex (60-74 min) | 176 | $171 | $720 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
160 | $66 | $259 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
125 | $2 | $7 |
| Injection, fulvestrant, 25 mg | 124 | $3 | $10 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
109 | $1 | $4 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 98 | $31 | $119 |
| Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg | 90 | $11 | $42 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
86 | $1 | $4 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
58 | $50 | $195 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $141 | $593 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $14 | $54 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
34 | $17 | $68 |
| Bone marrow aspiration A procedure to remove a small sample of liquid bone marrow for diagnostic testing. |
19 | $68 | $534 |
| Biopsy of bone marrow | 19 | $146 | $554 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
11.8% high complexity
76.0% medium
12.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,527
Total received (2018-2024)
Avg $5,075/year across 7 years
Top 14% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
1,530
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,426
2023
$5,466
2022
$4,723
2021
$3,825
2020
$4,903
2019
$5,154
2018
$5,030
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$716
AstraZeneca Pharmaceuticals LP
$462
Celgene Corporation
$382
Janssen Biotech, Inc.
$340
PFIZER INC.
$314
Incyte Corporation
$305
ABBVIE INC.
$277
Eisai Inc.
$271
Lilly USA, LLC
$252
Merck Sharp & Dohme LLC
$206
E.R. Squibb & Sons, L.L.C.
$204
Takeda Pharmaceuticals U.S.A., Inc.
$198
Astellas Pharma US Inc
$178
Gilead Sciences, Inc.
$167
Genentech USA, Inc.
$141
TerSera Therapeutics LLC
$132
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$111
Immunocore Limited
$107
Blueprint Medicines Corporation
$102
PharmaEssentia USA Corporation
$100
ADC Therapeutics America, Inc.
$97
Bayer Healthcare Pharmaceuticals Inc.
$93
Exelixis Inc.
$92
Alexion Pharmaceuticals, Inc.
$90
GENZYME CORPORATION
$88
EMD Serono, Inc.
$86
SUN PHARMACEUTICAL INDUSTRIES INC.
$79
SOBI, INC
$76
ARRAY BIOPHARMA INC
$75
Genmab U.S., Inc.
$64
Kite Pharma, Inc.
$49
JAZZ PHARMACEUTICALS INC.
$44
GlaxoSmithKline, LLC.
$44
Karyopharm Therapeutics Inc.
$43
Apellis Pharmaceuticals, Inc.
$32
SpringWorks Therapeutics, Inc.
$30
Pharmacosmos Therapeutics Inc.
$29
Tempus AI, Inc
$28
PUMA BIOTECHNOLOGY, INC.
$27
Ipsen Biopharmaceuticals, Inc
$27
Daiichi Sankyo Inc.
$26
TAIHO ONCOLOGY, INC.
$25
Mirati Therapeutics, Inc.
$20
Deciphera Pharmaceuticals Inc.
$20
Fennec Pharmaceuticals, Inc.
$19
Chiesi USA, Inc.
$19
BeiGene USA, Inc.
$18
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,285
AstraZeneca Pharmaceuticals LP
$1,880
E.R. Squibb & Sons, L.L.C.
$1,755
PFIZER INC.
$1,712
Amgen Inc.
$1,599
Incyte Corporation
$1,558
Celgene Corporation
$1,508
Genentech USA, Inc.
$1,453
GENZYME CORPORATION
$1,382
Puma Biotechnology, Inc.
$1,364
Janssen Biotech, Inc.
$1,287
Merck Sharp & Dohme Corporation
$1,035
Takeda Pharmaceuticals U.S.A., Inc.
$972
Astellas Pharma US Inc
$891
Lilly USA, LLC
$811
Seagen Inc.
$750
Bayer HealthCare Pharmaceuticals Inc.
$648
Exelixis Inc.
$629
Karyopharm Therapeutics Inc.
$618
Eisai Inc.
$576
Alexion Pharmaceuticals, Inc.
$543
Boehringer Ingelheim Pharmaceuticals, Inc.
$507
Merck Sharp & Dohme LLC
$495
Blueprint Medicines Corporation
$487
Gilead Sciences, Inc.
$426
TerSera Therapeutics LLC
$385
Regeneron Healthcare Solutions, Inc.
$362
Teva Pharmaceuticals USA, Inc.
$344
EMD Serono, Inc.
$316
ABBVIE INC.
$293
Bayer Healthcare Pharmaceuticals Inc.
$253
ARRAY BIOPHARMA INC
$248
Clovis Oncology, Inc.
$228
Daiichi Sankyo Inc.
$228
Kyowa Kirin, Inc.
$227
Pharmacyclics LLC, An AbbVie Company
$218
GlaxoSmithKline, LLC.
$217
Kite Pharma, Inc.
$204
TESARO, Inc.
$199
Seattle Genetics, Inc.
$193
PharmaEssentia USA Corporation
$186
Spectrum Pharmaceuticals Inc.
$182
Dova Pharmaceuticals
$180
BeiGene USA, Inc.
$168
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Janssen Scientific Affairs, LLC
$145
EISAI INC.
$145
TOLMAR Pharmaceuticals, Inc.
$145
Rigel Pharmaceuticals, Inc.
$137
Mirati Therapeutics, Inc.
$129
PUMA BIOTECHNOLOGY, INC.
$129
Heron Therapeutics, Inc.
$115
SOBI, INC
$113
MEDIVATION FIELD SOLUTIONS LLC
$109
Immunocore Limited
$107
ADC Therapeutics America, Inc.
$97
Helsinn Therapeutics (U.S.), Inc.
$95
Coherus Biosciences Inc.
$93
Taiho Oncology, Inc.
$90
Novocure Inc.
$87
Ipsen Biopharmaceuticals, Inc
$87
Pharmacyclics LLC, an AbbVie Company
$80
SUN PHARMACEUTICAL INDUSTRIES INC.
$79
Aurobindo Pharma USA, Inc.
$76
TAIHO ONCOLOGY, INC.
$73
Lexicon Pharmaceuticals, Inc.
$70
Stemline Therapeutics Inc.
$70
Deciphera Pharmaceuticals Inc.
$68
ImmunoGen, Inc.
$67
Genmab U.S., Inc.
$64
AMAG Pharmaceuticals, Inc.
$63
Secura Bio, Inc.
$61
MorphoSys, US Inc.
$61
Organon LLC
$60
Sun Pharmaceutical Industries Inc.
$59
Verastem, Inc.
$57
AbbVie Inc.
$49
Janssen Pharmaceuticals, Inc
$48
JAZZ PHARMACEUTICALS INC.
$44
Foundation Medicine, Inc.
$42
GE HealthCare
$39
Chiesi USA, Inc.
$35
AbbVie, Inc.
$33
Apellis Pharmaceuticals, Inc.
$32
Octapharma USA, Inc.
$30
SpringWorks Therapeutics, Inc.
$30
Pharmacosmos Therapeutics Inc.
$29
Tempus AI, Inc
$28
Emmaus Medical, Inc.
$25
Integra LifeSciences Corporation
$25
Myriad Genetic Laboratories, Inc.
$25
Acceleron Pharma, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
Sobi, Inc
$22
Agios Pharmaceuticals, Inc.
$21
Epizyme, Inc.,
$21
AVEO Pharmaceuticals, Inc.
$20
Verity Pharmaceuticals Inc.
$20
Sirtex Medical Inc
$19
Fennec Pharmaceuticals, Inc.
$19
Acrotech Biopharma LLC
$16
EUSA Pharma (US) LLC
$14
Top 3 companies account for 16.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BILAYER WOUND MATRIX (BWM) · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FERAHEME · FERRIPROX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAMIFANT · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORENCIA · OXBRYTA · Oncology · Onivyde · Optune · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · QINLOCK · QUZYTTIR · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
369
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bagdasarian is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bagdasarian experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Bagdasarian performed 33,265 filgrastim injection (zarxio) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bagdasarian receive payments from pharmaceutical companies?
Yes. Dr. Bagdasarian received a total of $35,527 from 102 companies across 1,530 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bagdasarian's costs compare to other hematology & oncology specialists in Glendale?
Dr. Bagdasarian's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bagdasarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Glendale
Browse hematology & oncology specialists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology